The global anesthesia and respiratory devices market was estimated at USD 15.3 billion in 2017, growing at a CAGR of 9.9% during the forecast period from 2019 – 2025. Factors such as increasing prevalence of chronic obstructive pulmonary diseases, growing healthcare awareness, and technological advancements are some of the prominent factors driving the global anesthesia and respiratory devices market. In addition, rising government support for healthcare in emerging economies stimulates the market growth. Government organizations in emerging economies are coming up with favorable healthcare reforms that open new avenues for anesthesia and respiratory device manufacturers in these countries.
Rising incidence of obstructive sleep apnea (OSA) and chronic obstructive pulmonary diseases (COPD) are the some of the major factors propelling the market for respiratory devices market segment globally during the study period. The respiratory devices market segment accounts for the largest share of the global anesthesia and respiratory devices market in 2017. The dominance of this market segment was majorly due to rising healthcare expenditure, especially in the U.S., along with cost effective and convenient medical treatment in a homecare environment, especially amongst the aging population also provides an impetus for growth of the respiratory devices market segment globally. Increasing medical tourism and rising healthcare expenditure in emerging economies for building up the healthcare infrastructure will subsequently drive the demand for anesthesia devices market.
The Anesthesia & Respiratory Devices market is expected to grow at a CAGR of 8.21% to reach U$ 81.9 billion in 2030.
.jpg "The Global Anesthesia And Respiratory Market 2020-2030 (USD Billion)")
Manufacturers are coming up with newer and technologically advanced devices which are useful and easy to monitor depth of anesthesia on the part of patients during surgery. Increasing awareness about the use of monitoring devices has also caused manufacturers to launch newer products. Ever-increasing awareness amongst people for the use of monitoring devices has accelerated the demand for anesthesia machines. Effective and safe treatment to high risk patients is a major concern amongst anesthesiologists. Hence, there is an increase in the demand for technologically sound and reliable anesthesia machines; which note multiple data about the patient in perioperative environment for effective treatment and critical decision making.
COPD is a degenerative lung disease that causes difficulty in breathing and is one of the leading causes of death. By 2020, COPD is expected to be the third leading cause of death globally. Currently, more than 500 million people worldwide suffer from COPD. The U.S. has the highest number (16.4 million) of people suffering from these diseases. Diagnosis rate of patients suffering from such diseases is increasing at 2% per annum in the developed countries. In emerging markets, it is increasing at more than 13% per annum. Such high incidence triggers demand for respiratory devices globally.
Geographically, North America dominated the global anesthesia and respiratory devices market in 2018 and is expected to retain its dominance during the forecast period. The dominance of this regional market was majorly due to increasing number of patients diagnosed with COPD. In addition, increasing geriatric population and favorable reimbursement policies for anesthesia and respiratory devices in the North American region also support the market growth. Thus, all the above mentioned factors collectively support the dominance of the North American anesthesia and respiratory devices market growth during the forecast period. Asia-Pacific anesthesia and respiratory devices market is estimated to be the most lucrative market owing to rising medical tourism in Asian countries, coupled with increasing government healthcare expenditure boosts the growth of the market in the region.
Anesthesia & Respiratory Devices Market Scope
| Metrics | Details |
| Base Year | 2023 |
| Historic Data | 2018-2022 |
| Forecast Period | 2024-2030 |
| Study Period | 2018-2030 |
| Forecast Unit | Value (USD) |
| Revenue forecast in 2030 | U$ 81.9 billion |
| Growth Rate | CAGR of 8.21% during 2020-2030 |
| Segment Covered | Device Type, Regions |
| Regions Covered | North America, Europe, Asia Pacific, South America, Middle East and Africa |
| Key Players Profiled | Teleflex Incorporated, SunMed, Smiths Group Plc., ResMed Inc., Medtronic Plc., Masimo Corporation, Koninklijke Philips N.V., Invacare Corporation, Hamilton Medical AG, and GE Healthcare. |
Key segments of the global anesthesia and respiratory devices market
Device Type Overview (USD Billion)
- Anesthesia Devices
- Anesthesia Machines
- Anesthesia Workstation
- Anesthesia Delivery Machines
- Anesthesia Ventilators
- Anesthesia Monitors
- Anesthesia Disposables
- Anesthesia Masks
- Anesthesia Accessories
- Anesthesia Machines
- Respiratory Devices
- Respiratory Devices
- Humidifiers
- Nebulizers
- Oxygen Concentrators
- Positive Airway Pressure Devices
- Reusable Resuscitators
- Ventilators
- Respiratory Inhalers
- Respiratory Measurement Devices
- Pulse Oximetry Systems
- Capnographs
- Spirometers
- Peak Flowmeters
- Respiratory Disposables
- Disposable Oxygen Masks
- Resuscitators
- Tracheostomy Tubes
- Oxygen Cannula
- Respiratory Devices
Regional Overview, (USD Billion)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- Korea
- India
- Southeast Asia
- Rest of Asia Pacific
- South America, Middle-East & Africa
- Brazil
- Egypt
- Saudi Arabia
- South Africa
- Nigeria
- Rest of the World
Frequently Asked Questions (FAQ) :
The market value of anesthesia & respiratory devices market in 2030 was U$ 81.9 billion
The anesthesia & respiratory devices market is growing at a CAGR of 8.21% over the forecast period.
The top companies that hold the market share in anesthesia & respiratory devices market are Teleflex Incorporated, SunMed, Smiths Group Plc., ResMed Inc., Medtronic Plc., Masimo Corporation, Koninklijke Philips N.V., Invacare Corporation, Hamilton Medical AG, and GE Healthcare.